STRS OHIO - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 103 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.

Quarter-by-quarter ownership
STRS OHIO ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$692
-13.0%
59,2000.0%0.00%0.0%
Q2 2023$795
-69.4%
59,200
-62.3%
0.00%
-25.0%
Q1 2023$2,601
+187.4%
156,900
+222.2%
0.00%0.0%
Q4 2022$905
-99.9%
48,700
-22.0%
0.00%0.0%
Q3 2022$800,000
+11.4%
62,400
-39.1%
0.00%
+33.3%
Q2 2022$718,000
-17.2%
102,500
-2.1%
0.00%0.0%
Q1 2022$867,000
+1.0%
104,700
-17.4%
0.00%0.0%
Q4 2021$858,000
+1.2%
126,800
-20.8%
0.00%0.0%
Q3 2021$848,000
+2.8%
160,000
+11.5%
0.00%0.0%
Q2 2021$825,000
-8.1%
143,500
-26.3%
0.00%0.0%
Q1 2021$898,000
+49.7%
194,800
+8.3%
0.00%
+50.0%
Q4 2020$600,000
+20.5%
179,800
+7.2%
0.00%0.0%
Q3 2020$498,000
-11.7%
167,700
+37.3%
0.00%0.0%
Q2 2020$564,000
-1.7%
122,100
-18.1%
0.00%
-33.3%
Q1 2020$574,000
+2.7%
149,1000.0%0.00%
+50.0%
Q4 2019$559,000
-56.1%
149,100
-37.8%
0.00%
-33.3%
Q3 2019$1,272,000
+96.6%
239,800
+42.3%
0.00%0.0%
Q2 2019$647,000
-33.4%
168,500
-11.6%
0.00%
-25.0%
Q1 2019$972,000
+166.3%
190,6000.0%0.00%
+100.0%
Q4 2018$365,000
-49.3%
190,6000.0%0.00%
-33.3%
Q3 2018$720,000
+3.4%
190,600
-14.6%
0.00%0.0%
Q2 2018$696,000
+30.6%
223,1000.0%0.00%
+50.0%
Q1 2018$533,000
-16.3%
223,100
+36.9%
0.00%
-33.3%
Q4 2017$637,000
+2175.0%
163,000
+576.3%
0.00%
Q1 2016$28,000
-52.5%
24,1000.0%0.00%
Q4 2015$59,000
-18.1%
24,1000.0%0.00%
Q3 2015$72,000
-27.3%
24,1000.0%0.00%
Q2 2015$99,00024,1000.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 213,609$1,446,0002.75%
GABLES CAPITAL MANAGEMENT INC. 449,164$3,041,0001.81%
Prairiewood Capital, LLC 261,403$1,770,0001.40%
ARMISTICE CAPITAL, LLC 9,572,000$64,802,0001.06%
Quantedge Capital Pte Ltd 360,100$2,438,0001.03%
SummerHaven Investment Management, LLC 151,384$1,025,0000.55%
GLOBEFLEX CAPITAL L P 609,030$4,124,0000.42%
EAM Global Investors LLC 347,899$2,355,0000.42%
Lanham O'Dell & Company, Inc. 50,000$339,0000.27%
EAM Investors, LLC 239,071$1,619,0000.27%
View complete list of CATALYST PHARMACEUTICALS INC shareholders